Encephalx | Recherche et développement en produits crâniens

We are
the universal choice
in cranial products

About Us

EncephalX is committed to redefining the standard of care for patients with traumatic brain injuries or strokes. Conventionally treated in two surgeries, our Dynamic Cranioplasty System (DCPS)™ offers a safer, more efficient solution that enhances patient outcomes and reduces recovery time with a streamlined, single-procedure approach.

With a diverse team of professionals specializing in engineering, neurosurgery, clinical research and regulatory affairs, we focus on providing tangible, real-world solutions to complex challenges in the operating room, ultimately improving the quality of life for patients.

Our mission

To improve the quality of life of patients treated through neurosurgery with adapted products that promote a rapid and uncomplicated recovery.

We aspire to become a world leader in the development, certification and commercialization of dynamic implants.

Towards the summit of medical devices

We aspire to become a world leader in the development, certification and commercialization of dynamic implants.

Universal device,
a peace of mind

The DCPS's simplicity, will ensure trouble-free surgeries, keeping patients and health care professionals' heads at peace.

Benefits
for both parties.

2nd surgery
avoided

By eliminating the need for a second surgery, the risks associated with the treatment will be considerably reduced.

Safe

Surgery

Our device provides a cerebral protection that limits the possibility of injuries caused by impacts and removes the risk of skin collapse, better known as "sinking flap syndrome".

Improved
Aesthetic

As one of the thinnest plates available on the market, it will promote rapid healing to improve the appearance of scars.

Reduced
time

The rehabilitation period for the surgical treatment of an increased intracranial pressure will now be reduced by several weeks due to the combined procedure.

Need more information ?

Do not hesitate to contact us for more information. It will be our pleasure to answer you and to better inform you on the company, the projects and the next steps for EncephalX.

Solutions
to everyday problems

Head injuries are the leading cause of death for young adults in North America. However, the care provided is associated to a lot of complications and is very costly for the health care system. The treatment involves the removal of a large part of the skull for a period of two months. After this initial procedure, these patients' brains are left extremely vulnerable until their bone flap is reinstalled during the second surgery.

DCPS™ Clears
Its Pre-Clinical Milestones

News - August 2026

EncephalX has completed the pre-clinical program for the Dynamic CranioPlasty System (DCPS™), a key step toward eliminating the second cranioplasty surgery for decompressive craniectomy patients. With these results in hand, our team is now preparing for our first-in-human clinical study. We look forward to sharing more as we move closer to the clinic.

Closing of a $2.25M
Pre-Seed Round

News - January 2026

With this pre-seed round closed, EncephalX is advancing toward first-in-human use while continuing to build partnerships across clinical, regulatory, and industrial domains.

learn more

EncephalX launches animal trials

News - December 2025

With a goal of demonstrating the safety of our implants, we have begun GLP implantation in animals. This is a very important step in our regulatory process.

EncephalX obtains its first US patent

News - November 2025

This is another step forward in the execution of our intellectual property strategy, which will give us a significant advantage in the field of dynamic implants.

Important milestone reached

News - January 2025

Our team has demonstrated the exceptional ability of our implants to provide intracranial decompression through a series of cadaver implantations! A big thank you to everyone who participated, especially the five surgeons who were involved!

Jean-Pierre Desmarais

Medical Device Expert

Jean-Pierre Desmarais is a serial entrepreneur with over 40 years of experience in the medical device industry. He took complex cardiology and orthopaedic technologies from inception to global approval, leading to the acquisition of CryoCath by Medtronic and the sale of Piramal Bio-Orthopedics’ assets to Smith+Nephew. He is currently President and CEO of Leaflet Solutions.

Vincent Nault

Digital Health Expert

Vincent Nault is a scientist and entrepreneur who co-founded Lumed and led it to its acquisition by bioMérieux, a world leader in in vitro diagnostics. He is now Global Vice-President, Digital Health Innovation at bioMérieux.

Simon Lapointe

CEO & Founder

Simon Lapointe is the Founder and CEO of EncephalX. A bioengineer with a background in research, finance, and entrepreneurship, he was named a Top 20 Under 40 in Canadian life sciences 2025.